On this page of StockholderLetter.com we present the latest annual shareholder letter from CROSS COUNTRY HEALTHCARE INC — ticker symbol CCRN. Reading current and past CCRN letters to shareholders can bring important insights into the investment thesis.
2 02 4 A NNUA L R E PORT
L E A D E R S H I P. I N N O V AT I O N . ACCOU N TA BI L I TY.

Dear Shareholders,
As we re   ect on 2024 and 2025 thus far, Cross Country Healthcare, Inc. (   Cross Country   )
navigated signi   cant changes across the healthcare landscape, including workforce
shortages, rising costs, and shifting client needs. Through it all, we remained focused on
disciplined execution, operational efficiency, and delivering the workforce solutions our
clients and professionals relied on every day.
We took deliberate steps to strengthen our foundation, advance our technology
capabilities, and position Cross Country to serve the evolving needs of healthcare,
homecare, and education communities. These efforts were designed not for short-term
gains but to ensure long-term stability, adaptability, and value for all stakeholders.
2024 PERFORMANCE HIGHLIGHTS
Generated $1.3 billion in revenue across our portfolio.
Maintained a strong balance sheet with $82 million of cash on hand and no debt as
of year-end.
Drove cost savings by signi   cantly expanding our investment in our low-cost center
of excellence in India.
Repurchased and retired over 2.4 million shares of common stock for $36.8 million.
Physician and Homecare Staffing experienced year-over-year revenue growth.
Advanced technology investments, expanding Intellify   across MSP programs and
elevating the Xperience    app, a mobile-   rst platform for healthcare professionals to
manage assignments, scheduling, and real-time engagement.
Our    nancial and operational progress in 2024 re   ected this steady approach.
2025 AND LOOKING AHEAD
During 2025, our focus has remained on operational discipline, technology-driven
innovation, and strengthening the relationships that matter most     with our clients, as
well as the clinicians, educators, and homecare professionals, who power our workforce
solutions every day.
We also expect that our proposed merger with Aya Healthcare, Inc. will close in the fourth
quarter of 2025.
A STEADY PATH FORWARD
With a diversi   ed portfolio, strong client and professional relationships, and a proven
record of disciplined execution, Cross Country remains committed to serving the needs of
clients, clinicians, educators, homecare professionals, and stakeholders with consistency
and reliability.
Sincerely,
John A. Martins
President and CEO
Form 10-K
 • shareholder letter icon 10/27/2025 Letter Continued (Full PDF)
 • stockholder letter icon 4/3/2023 CCRN Stockholder Letter
 • stockholder letter icon 4/1/2024 CCRN Stockholder Letter
 • stockholder letter icon More "Diagnostics" Category Stockholder Letters
 • Benford's Law Stocks icon CCRN Benford's Law Stock Score = 95


CCRN Shareholder/Stockholder Letter Transcript:

2 02 4 A NNUA L R E PORT
L E A D E R S H I P. I N N O V AT I O N . ACCOU N TA BI L I TY.


Dear Shareholders,
As we re   ect on 2024 and 2025 thus far, Cross Country Healthcare, Inc. (   Cross Country   )
navigated signi   cant changes across the healthcare landscape, including workforce
shortages, rising costs, and shifting client needs. Through it all, we remained focused on
disciplined execution, operational efficiency, and delivering the workforce solutions our
clients and professionals relied on every day.
We took deliberate steps to strengthen our foundation, advance our technology
capabilities, and position Cross Country to serve the evolving needs of healthcare,
homecare, and education communities. These efforts were designed not for short-term
gains but to ensure long-term stability, adaptability, and value for all stakeholders.
2024 PERFORMANCE HIGHLIGHTS
Generated $1.3 billion in revenue across our portfolio.
Maintained a strong balance sheet with $82 million of cash on hand and no debt as
of year-end.
Drove cost savings by signi   cantly expanding our investment in our low-cost center
of excellence in India.
Repurchased and retired over 2.4 million shares of common stock for $36.8 million.
Physician and Homecare Staffing experienced year-over-year revenue growth.
Advanced technology investments, expanding Intellify   across MSP programs and
elevating the Xperience    app, a mobile-   rst platform for healthcare professionals to
manage assignments, scheduling, and real-time engagement.
Our    nancial and operational progress in 2024 re   ected this steady approach.
2025 AND LOOKING AHEAD
During 2025, our focus has remained on operational discipline, technology-driven
innovation, and strengthening the relationships that matter most     with our clients, as
well as the clinicians, educators, and homecare professionals, who power our workforce
solutions every day.
We also expect that our proposed merger with Aya Healthcare, Inc. will close in the fourth
quarter of 2025.
A STEADY PATH FORWARD
With a diversi   ed portfolio, strong client and professional relationships, and a proven
record of disciplined execution, Cross Country remains committed to serving the needs of
clients, clinicians, educators, homecare professionals, and stakeholders with consistency
and reliability.
Sincerely,
John A. Martins
President and CEO

Form 10-K



shareholder letter icon 10/27/2025 Letter Continued (Full PDF)
 

CCRN Stockholder/Shareholder Letter (CROSS COUNTRY HEALTHCARE INC) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.